Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125350881 | 12535088 | 1 | I | 20160417 | 20160704 | 20160707 | 20160707 | EXP | AU-ROCHE-1788012 | ROCHE | 75.00 | YR | F | Y | 0.00000 | 20160707 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125350881 | 12535088 | 1 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | U | 0 | ||||||||||
| 125350881 | 12535088 | 2 | PS | Oseltamivir | OSELTAMIVIR | 1 | Oral | U | 21087 | 150 | MG | QD | |||||||
| 125350881 | 12535088 | 3 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | U | 0 | 500 | MG | ||||||||
| 125350881 | 12535088 | 4 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 4 | G | QD | |||||||
| 125350881 | 12535088 | 5 | SS | Lenalidomide | LENALIDOMIDE | 1 | Oral | U | 0 | 25 | MG | ||||||||
| 125350881 | 12535088 | 6 | SS | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | 0 | 4.5 | G | ||||||||
| 125350881 | 12535088 | 7 | SS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Oral | Y | 0 | 300 | MG | QD | |||||||
| 125350881 | 12535088 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 9 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 10 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 125350881 | 12535088 | 11 | C | IRBESARTAN. | IRBESARTAN | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 12 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 13 | C | THYROXINE | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 14 | C | VALACICLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125350881 | 12535088 | 15 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125350881 | 12535088 | 1 | Product used for unknown indication |
| 125350881 | 12535088 | 2 | Product used for unknown indication |
| 125350881 | 12535088 | 3 | Product used for unknown indication |
| 125350881 | 12535088 | 4 | Product used for unknown indication |
| 125350881 | 12535088 | 5 | Product used for unknown indication |
| 125350881 | 12535088 | 6 | Product used for unknown indication |
| 125350881 | 12535088 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125350881 | 12535088 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125350881 | 12535088 | Oedema peripheral | |
| 125350881 | 12535088 | Pruritus | |
| 125350881 | 12535088 | Rash erythematous |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125350881 | 12535088 | 1 | 20160411 | 0 | ||
| 125350881 | 12535088 | 2 | 20160415 | 0 | ||
| 125350881 | 12535088 | 3 | 20160416 | 0 | ||
| 125350881 | 12535088 | 4 | 20160417 | 0 | ||
| 125350881 | 12535088 | 5 | 20160411 | 0 | ||
| 125350881 | 12535088 | 6 | 20160415 | 0 | ||
| 125350881 | 12535088 | 7 | 20160417 | 0 |